Text of the Recommendations for Changes in Roles of Chair and President of $12 Billion California Stem Cell Agency

Below is the text of what the National Academy of Medicine had to say in 2012 about the dual executive arrangement at the California stem cell agency. Some of the details are outdated but the situation is still largely in place and is written into state law. Here is a link to the governance chapter of the full report. 

“The chairperson’s primary responsi…